Addressing the mutational spectrum of co-occurring mutations, all 18 RUNX1-mutated and 470 wt-cases were evaluated for 53 additional AML-related genes assayed by targeted NGS (Fig. 3, Supplementary Table S2b). Here, RUNX1 is linked to acute myeloid leukemia.